Study summary · research use only
Polymeric Particle BAM15 Targeting Macrophages Attenuates the Severity of LPS-Induced Sepsis: A Proof of Concept for Specific Immune Cell-Targeted Therapy
Plain-language summary
Paraphrased from the published abstract below — not a verdict on whether anything works.
This study used human THP-1 and mouse RAW264.7 macrophage cell lines in vitro, plus an LPS-induced sepsis mouse model in vivo, to test BAM15 (a mitochondrial uncoupling agent) delivered free or loaded into PLGA particles, targeting macrophage cell energy metabolism. The abstract reports that both free BAM15 and BAM15-loaded particles interfered with M1 but not M2 macrophage polarization, reduced M1 inflammatory response, and increased M2 signature gene expression with restored mitochondrial activity in RAW264.7 cells. BAM15 particles, but not free BAM15, showed effects specific to macrophages rather than neutrophils and were captured by splenic and liver macrophages in vivo. Both BAM15 and BAM15 particles reduced sepsis severity in LPS-induced sepsis mice, and BAM15 particles, but not free BAM15, reduced LPS-induced liver injury by lowering hepatic inflammation.
Abstract
Macrophage polarization requires different energy sources and metabolic processes. Therefore, cell energy interference to alter macrophage functions has been proposed as a treatment for severe inflammatory diseases, including sepsis. In this study, targeting cell energy using BAM15 (a mitochondrial uncoupling agent) in human THP-1 and mouse RAW264.7 macrophages prominently interfered with M1 but not M2 polarization. Free BAM15 (BAM15) and BAM15-loaded PLGA particles (BAM15 particles) reduced the inflammatory response of M1 macrophages and enhanced the expression of M2 signature genes with the restoration of mitochondrial activity (extracellular flux analysis) in RAW264.7 cells. Furthermore, BAM15 particles but not BAM15 showed specific effects on the inflammatory response of macrophages but not neutrophils, and the particles were actively captured by splenic and liver macrophages in vivo. Administration of BAM15 and BAM15 particles attenuated the severity of sepsis in LPS-induced sepsis mice. Interestingly, BAM15 particles but not BAM15 alleviated LPS-induced liver injury by reducing hepatic inflammation. Our findings substantiate the superior efficacy of macrophage-targeted therapy using a BAM15 particle-delivery system and provide further support for clinical development as a potential therapy for severe inflammatory diseases.
pepmg summarizes the peer-reviewed literature and links to every source — it sells nothing, ships nothing, and gives no medical, dosing, or human-use guidance. Don't just trust this summary: follow the citation to its source and read it yourself. Research use only.